Sarcopenia risk | Total | p value | |||
---|---|---|---|---|---|
< 4 No risk | = > 4 High risk | ||||
HAQ | |||||
Male | ≥ 1 High risk | 11 (11.1%) | 29 (78.4%) | 40 (29.4%) | < 0.001 |
Female | ≥ 1 High risk | 22 (18.3%) | 100 (73.0%) | 122 (47.5%) | < 0.001 |
Total | ≥ 1 High risk | 33 (15.1%) | 129 (74.1%) | 162 (41.2%) | < 0.001 |
Fall score | |||||
Male | < 2.50 No risk | 64 (65.3%) | 12 (32.4%) | 76 (56.3%) | < 0.001 |
2.5– < 3.5 Moderate risk | 16 (16.3%) | 2 (5.4%) | 18 (13.3%) | ||
≥ 3.5 High risk | 18 (18.4%) | 23 (62.2%) | 41 (30.4%) | ||
Female | < 2.50 No risk | 68 (57.1%) | 43 (31.4%) | 111 (43.4%) | < 0.001 |
2.5– < 3.5 Moderate risk | 18 (15.1%) | 18 (13.1%) | 36 (14.1%) | ||
≥ 3.5 High risk | 33 (27.7%) | 76 (55.5%) | 109 (42.6%) | ||
Total | < 2.50 No risk | 132 (60.8%) | 55 (31.6%) | 187 (47.8%) | < 0.001 |
2.5– < 3.5 Moderate risk | 34 (15.7%) | 20 (11.5%) | 54 (13.8%) | ||
≥ 3.5 High risk | 51 (23.5%) | 99 (56.9%) | 150 (38.4%) |